Boyd, Michael R.
LLC,
United States
2025 Rank: 9255
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 28 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9255 | 9821 |
| Total Cites | 43560 | 46260 |
| H-index | 86 | 93 |
| Hm-index | 34 | 36 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 183 | 186 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2935 | 3183 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 35455 | 37022 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 32754 | 33495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
5.84%
|
|
Boyd, Michael R.
ADT PHARMACEUTICALS, LLC,
United States
2024 Rank: 8574
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 23 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8574 | 9181 |
| Total Cites | 42296 | 44976 |
| H-index | 84 | 92 |
| Hm-index | 34 | 35 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 180 | 183 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2831 | 3076 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 34359 | 35914 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 31756 | 32489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.38 |
| Self-Citation Percentage |
5.96%
|
|
Boyd, Michael R.
ADT PHARMACEUTICALS, LLC,
United States
2023 Rank: 8029
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 20 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8029 | 8718 |
| Total Cites | 40952 | 43617 |
| H-index | 83 | 90 |
| Hm-index | 34 | 35 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 170 | 173 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2720 | 2963 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 33242 | 34786 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 30721 | 31451 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
6.11%
|
|
Boyd, Michael R.
National Cancer Institute (NCI),
United States
2022 Rank: 7452
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 18 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7452 | 8106 |
| Total Cites | 39423 | 42068 |
| H-index | 82 | 88 |
| Hm-index | 34 | 35 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 160 | 163 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2576 | 2818 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 31957 | 33494 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 29531 | 30254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
6.29%
|
|
Boyd, Michael R.
ADT PHARMACEUTICALS, LLC,
United States
2021 Rank: 7168
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 19 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7168 | 7778 |
| Total Cites | 38474 | 41094 |
| H-index | 80 | 86 |
| Hm-index | 33 | 34 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 158 | 161 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2499 | 2738 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 31176 | 32703 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 28834 | 29550 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.39 |
| Self-Citation Percentage |
6.38%
|
|
Boyd, Michael R.
National Cancer Institute,
United States
2020 Rank: 6645
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Organic Chemistry
Rank in SubField 1: 22 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6645 | 7134 |
| Total Cites | 36521 | 39124 |
| H-index | 78 | 84 |
| Hm-index | 32 | 34 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 155 | 158 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 2374 | 2612 |
| Number of Single+First+Last Authored Papers | 312 | 312 |
| Total Cites to Single+First+Last Authored Papers | 29541 | 31056 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27289 | 27997 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.40 |
| Self-Citation Percentage |
6.65%
|
|